- D57.40 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D57.40 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D57.40 – other international versions of ICD-10 D57.40 may differ.
ICD-10-CM D57.40 is grouped within Diagnostic Related Group(s):
- 791 Prematurity with major problems
- 793 Full term neonate with major problems
- 811 Red blood cell disorders with mcc
- 812 Red blood cell disorders without mcc
Applicable To
- Microdrepanocytosis
- Sickle-cell thalassemia NOS
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D57.40:
- microdrepanocytosis > Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
- thalassemia > sickle-cell D57.1
- without crisis > thalassemia D57.40
- with thalassemia > sickle-cell D57.1
- without crisis > with thalassemia D57.40